Genocea Biosciences
GNCA
#11355
Rank
โ‚ฌ0 M
Marketcap
0,00009077ย โ‚ฌ
Share price
-85.71%
Change (1 day)
N/A
Change (1 year)

EPS for Genocea Biosciences (GNCA)

EPS in 2022 (TTM): -0,46ย โ‚ฌ

According to Genocea Biosciences 's latest financial reports the company's current EPS (TTM) is -0,47ย โ‚ฌ. In 2021 the company made an earnings per share (EPS) of -0,44ย โ‚ฌ an increase over its 2020 EPS that were of -1,05ย โ‚ฌ.

EPS history for Genocea Biosciences from 2014 to 2022

Annual EPS

Year EPS Change
2022 (TTM)-0,46ย โ‚ฌ5.64%
2021-0,44ย โ‚ฌ-58.62%
2020-1,05ย โ‚ฌ-48.21%
2019-2,03ย โ‚ฌ
2017-14,38ย โ‚ฌ13.14%
2016-12,71ย โ‚ฌ-3.31%
2015-13,14ย โ‚ฌ-23.31%
2014-17,14ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
0,64ย โ‚ฌ-236.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
0,90ย โ‚ฌ-290.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-1,38ย โ‚ฌ 192.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
1,83ย โ‚ฌ-488.46%๐Ÿ‡บ๐Ÿ‡ธ USA
iBio
IBIO
-0,68ย โ‚ฌ 44.23%๐Ÿ‡บ๐Ÿ‡ธ USA